Bacteria do not naturally synthesize insulin. It is possible however to implant human genetic material containing the insulin gene into the bacterial DNA. The mutant bacteria then multiply and produce human insulin. The insulin is isolated and purified for later commercialization. This biotechnology is known as the recombinant DNA technology.
Besides human insulin the pharmaceutical industry also produces insulin to be used by humans made from the pancreas of pigs and cows.
